Vertex Pharmaceuticals Incorporated shares owned by Advantus Capital Management
Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Advantus Capital Management
from 13F filings
Historical chart of Advantus Capital Management investment in Vertex Pharmaceuticals Incorporated
Tip: Access up to 7 years of quarterly data
All positions including Vertex Pharmaceuticals Incorporated held by Advantus Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Vertex Pharmaceuticals Incorporated by Advantus Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $4.8M | 12k | 391.64 |
| 2025-06-30 | $6.0M | 13k | 445.20 |
| 2025-03-31 | $6.6M | 14k | 484.82 |
| 2024-12-31 | $5.6M | 14k | 402.70 |
| 2024-09-30 | $6.6M | 14k | 465.08 |
| 2024-06-30 | $6.9M | 15k | 468.72 |
| 2024-03-31 | $6.3M | 15k | 418.01 |
| 2023-12-31 | $6.6M | 16k | 406.89 |
| 2023-09-30 | $6.4M | 19k | 347.74 |
| 2023-06-30 | $7.6M | 22k | 351.91 |
| 2023-03-31 | $6.9M | 22k | 315.07 |
| 2022-12-31 | $6.3M | 22k | 288.78 |
| 2022-09-30 | $6.2M | 22k | 289.53 |
| 2022-06-30 | $6.0M | 21k | 281.78 |
| 2022-03-31 | $5.6M | 21k | 260.97 |
| 2021-12-31 | $4.7M | 22k | 219.58 |
| 2021-09-30 | $4.1M | 22k | 181.40 |
| 2021-06-30 | $4.6M | 23k | 201.64 |
| 2021-03-31 | $4.9M | 23k | 214.89 |
| 2020-12-31 | $5.6M | 24k | 236.35 |
| 2020-09-30 | $6.6M | 24k | 272.11 |
| 2020-06-30 | $7.1M | 25k | 290.32 |
| 2020-03-31 | $6.1M | 26k | 237.95 |
| 2019-12-31 | $5.7M | 26k | 218.95 |
| 2019-09-30 | $4.6M | 27k | 169.41 |
| 2019-06-30 | $5.0M | 27k | 183.37 |
| 2019-03-31 | $4.9M | 27k | 183.95 |
| 2018-12-31 | $4.4M | 27k | 165.71 |
| 2018-09-30 | $5.1M | 26k | 192.76 |
| 2018-06-30 | $4.5M | 26k | 169.95 |
| 2018-03-31 | $4.3M | 26k | 162.98 |
| 2017-12-31 | $3.9M | 26k | 149.85 |
| 2017-09-30 | $3.9M | 26k | 152.03 |
| 2017-06-30 | $3.2M | 25k | 128.88 |
| 2017-03-31 | $2.7M | 25k | 109.35 |
| 2016-12-31 | $1.8M | 25k | 73.66 |
| 2016-09-30 | $2.1M | 25k | 87.23 |
| 2016-06-30 | $2.1M | 24k | 86.04 |
| 2016-03-31 | $1.9M | 24k | 79.50 |
| 2015-12-31 | $3.0M | 24k | 125.85 |
| 2015-09-30 | $2.4M | 23k | 104.15 |
| 2015-06-30 | $2.9M | 23k | 123.49 |
| 2015-03-31 | $2.7M | 23k | 117.97 |
| 2014-12-31 | $2.6M | 22k | 118.80 |
| 2014-09-30 | $2.4M | 21k | 112.31 |
| 2014-06-30 | $2.0M | 21k | 94.68 |
| 2014-03-31 | $1.5M | 21k | 70.72 |
| 2013-12-31 | $1.5M | 21k | 74.30 |
| 2013-09-30 | $1.6M | 21k | 75.84 |
| 2013-06-30 | $2.6M | 33k | 79.87 |
| 2013-03-31 | $1.8M | 33k | 54.99 |
| 2012-12-31 | $1.4M | 33k | 41.94 |
| 2012-09-30 | $1.8M | 33k | 55.95 |
| 2012-06-30 | $1.8M | 32k | 55.94 |
| 2012-03-31 | $1.3M | 32k | 40.99 |
| 2011-12-31 | $1.1M | 32k | 33.21 |
| 2011-09-30 | $1.4M | 31k | 44.53 |
More positions owned by Advantus Capital Management
View all positions for Advantus Capital Management
Top funds holding Vertex Pharmaceuticals Incorporated
View all funds holding Vertex Pharmaceuticals Incorporated